NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients.

Author(s): Meng QH, Krahn J

Publication: Clin Chem Lab Med, 2008, Vol. 46, Page 396-400

PubMed ID: 18254716 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to explain discrepant results obtained from a hemodialysis patient when plasma albumin quantification was performed by bromocresol green (BCG) versus the bromocresol purple (BCP) method.

Conclusion of Paper

No effect of in vivo treatment with heparin was found on albumin levels in serum, EDTA-plasma or heparinized plasma. However, collection of plasma into tubes containing lithium heparin resulted in a dose dependent decreased quantification of albumin by the BCG but not BCP method. No effect of quantification method was observed in EDTA-plasma or serum samples.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of in vivo heparin administration and collection anticoagulant on plasma and serum albumin levels by the BCG and BCP methods.

    Summary of Findings:

    No effect of in vivo administration of heparin on albumin concentration in serum or plasma collected in EDTA, or heparinized tubes was observed in a single patient by either the BCP or the BCG method. However, collection of plasma in lithium heparin tubes resulted in significantly lower albumin levels by the BCG method than BCP in 30 non-renal patients (31.2 versus 34.1 g/L, p<0.001) and 30 hemodialysis patients (28.6 versus 32.8 g/L, p<0.001). The effect of heparin on plasma albumin levels was dose dependent. Heparinized plasma albumin levels were significantly lower from serum albumin levels only when quantified by BCG (31.2 versus 34.8 in non-renal patients p<0.001). Further, no effect of quantification method was observed on serum albumin levels. In conclusion, while in vivo heparin administration does not alter albumin quantification, the presence of lithium heparin in the collection tube caused decreased albumin quantification by the BCG but not BCP method.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Other diagnoses
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Diagnosis/ patient condition Renal failure on hemodialysis
    Preaquisition Other drugs Heparin
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Biospecimen Acquisition Anticoagulant Lithium heparin
    EDTA
    Clinical chemistry/auto analyzer Specific Technology platform Bromocresol purple (Beckman)
    Bromocresol green (Roche)

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...